Page last updated: 2024-08-16

tibolone and Cardiometabolic Syndrome

tibolone has been researched along with Cardiometabolic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gram, J; Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO1

Trials

1 trial(s) available for tibolone and Cardiometabolic Syndrome

ArticleYear
The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:6

    Topics: Blood Pressure; Body Composition; C-Peptide; Cardiovascular Diseases; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Metabolic Syndrome; Middle Aged; Norpregnenes; Tissue Plasminogen Activator; Treatment Outcome; Triglycerides

2008
chemdatabank.com